Cargando…
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
This case series examines the incidence, timing, and characteristics of mammographic axillary adenopathy following COVID-19 vaccination.
Autores principales: | Robinson, Kristin A., Maimone, Santo, Gococo-Benore, Denise A., Li, Zhuo, Advani, Pooja P., Chumsri, Saranya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299355/ https://www.ncbi.nlm.nih.gov/pubmed/34292295 http://dx.doi.org/10.1001/jamaoncol.2021.3127 |
Ejemplares similares
-
Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021) -
Breast Cancer Screening and Axillary Adenopathy in the Era of
COVID-19 Vaccination
por: Wolfson, Stacey, et al.
Publicado: (2022) -
Re: Unilateral axillary adenopathy in the setting of COVID-19 vaccine, Clinical Imaging, January 2021
por: Finnegan, John, et al.
Publicado: (2021) -
Unilateral axillary Adenopathy in the setting of COVID-19 vaccine
por: Mehta, Nishi, et al.
Publicado: (2021) -
Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma
por: Ashoor, Arwa, et al.
Publicado: (2021)